Biotech

All Articles

GSK's long-acting breathing problem drug cut in half assaults in period 3

.GSK's long-acting breathing problem procedure has actually been presented to cut in half the amount...

AstraZeneca, Daiichi unpack Dato-DXd's total survival neglect

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has fallen short to i...

Roivant introduces brand new 'vant' to evolve Bayer hypertension med

.Matt Gline is actually back along with a new 'vant' firm, after the Roivant Sciences CEO paid out B...

Viridian eye condition period 3 smash hits, progressing press to rival Amgen

.Viridian Therapies' phase 3 thyroid eye health condition (TED) scientific trial has attacked its ow...

Bain reveals $3B fund for life scientific research firms

.With a strong record for pinpointing rough diamonds, Bain Funding Daily Life Sciences (BCLS) has be...

Genentech's cancer restructure brought in 'for scientific causes'

.The latest selection to merge Genentech's pair of cancer cells divisions was created "clinical caus...

Tern dental GLP-1 presents 5% fat loss at 1 month at greatest dose

.Terns Pharmaceuticals' decision to drop its liver ailment ambitions may however settle, after the b...

Merck, Daiichi repeat very early results in small cell lung cancer with updated ADC data

.Merck &amp Co.'s long-running effort to land a hit on small mobile lung cancer (SCLC) has actually ...

Boehringer, Bayer advancement bronchi cancer drugs toward Astra struggle

.Some people with non-small tissue bronchi cancer (NSCLC) possess anomalies in a gene called individ...

MBX aims for $136M IPO to take rival to Ascendis into phase 3

.MBX has actually expanded plans to absorb over $136 million from its IPO as the biotech seeks to ca...